Results 201 to 210 of about 681,456 (227)
Some of the next articles are maybe not open access.

Consideration of the biosimilar drug lag and loss among Japan, the USA, and the EU

Naunyn-Schmiedeberg's Archives of Pharmacology
Aya Hariu   +2 more
semanticscholar   +1 more source

Healthcare system conversion to a biosimilar: Trials and tribulations

American Journal of Health-System Pharmacy, 2021
Simon W Lam
exaly  

Outlook For Biosimilar Molecules Entering Croatian Pharmaceutical Market In The Period From 2016 To 2020

Clinical Therapeutics, 2016
R, Likic   +7 more
openaire   +2 more sources

Clinical safety of biosimilar recombinant human erythropoietins

Expert Opinion on Drug Safety, 2012
Ivo Abraham, Karen Macdonald
exaly  

Clinical safety of biosimilar recombinant human granulocyte colony-stimulating factors

Expert Opinion on Drug Safety, 2013
Ivo Abraham, Karen Macdonald
exaly  

Home - About - Disclaimer - Privacy